Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with poor
prognosis and increased incidence. Surgical resection R0 remains the most important …

Objective: To evaluate the outcomes of pancreatic cancer [pancreatic ductal
adenocarcinoma (PDAC)] surgery with concomitant portal vein resection (PVR), focusing on …

Background The results of laparoscopic pancreaticoduodenectomy combining with
mesentericoportal vein resection and reconstruction (LPD-MPVRs) for pancreatic head …

Background Although primary end-to-end anastomosis is preferred for portal vein-superior
mesenteric vein (PV-SMV) reconstruction, interposition graft use may be required in some …

Background Advancements in multiagent chemotherapy have expanded the surgical
indications for pancreatic cancer. Although pancreaticoduodenectomy (PD) with portal vein …

Objective: To investigate the incidence and risk factors of portomesenteric venous
thrombosis (PVT) after pancreatic cancer surgery with portomesenteric venous resection …

Background Universal surgical prophylaxis for pancreatoduodenectomy (PD) is practiced,
with cephalosporins recommended in most guidelines. Recent studies suggest piperacillin …

Abstract Background and Aim The study aims to develop a hybrid machine learning model
for predicting resectability of the pancreatic cancer, which is based on computed …

Background Portal vein resection and reconstruction in locally advanced pancreatic cancer
represents a potentially curative treatment in selected patients without increasing surgical …

Background Porto-mesenteric vein (PMV) infiltration of pancreatic cancer is classified as
borderline resectable cancer. For en-bloc resectability, the probability of PMV resection and …